GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » EPS without NRI

Tci Gene (ROCO:6879) EPS without NRI : NT$0.44 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene EPS without NRI?

Tci Gene's earnings per share without non-recurring items for the six months ended in Dec. 2023 was NT$0.14. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.44.

During the past 12 months, Tci Gene's average earnings per share (NRI) Growth Rate was -85.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -38.60% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Tci Gene's EPS without NRI or its related term are showing as below:

ROCO:6879' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -38.6   Med: -20.1   Max: -1.6
Current: -38.6

During the past 5 years, Tci Gene's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -1.60% per year. The lowest was -38.60% per year. And the median was -20.10% per year.

ROCO:6879's 3-Year EPS without NRI Growth Rate is ranked worse than
86.21% of 1291 companies
in the Biotechnology industry
Industry Median: 4.9 vs ROCO:6879: -38.60

Tci Gene's EPS (Diluted) for the six months ended in Dec. 2023 was NT$0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.44.

Tci Gene's EPS (Basic) for the six months ended in Dec. 2023 was NT$0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.44.


Tci Gene EPS without NRI Historical Data

The historical data trend for Tci Gene's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene EPS without NRI Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
3.09 1.91 4.68 2.95 0.44

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only 3.18 3.05 -0.09 0.30 0.14

Competitive Comparison of Tci Gene's EPS without NRI

For the Biotechnology subindustry, Tci Gene's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tci Gene's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Tci Gene's PE Ratio without NRI falls into.



Tci Gene EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tci Gene  (ROCO:6879) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tci Gene EPS without NRI Related Terms

Thank you for viewing the detailed overview of Tci Gene's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines